New combo therapy aims to boost rectal cancer remission without surgery
NCT ID NCT07581626
First seen May 15, 2026 · Last updated May 19, 2026 · Updated 2 times
Summary
This study tests a new treatment plan for people with a certain type of advanced rectal cancer. The approach combines a short course of radiation with chemotherapy, targeted therapy, and immunotherapy before any surgery. The goal is to see if this combination can make the tumor disappear completely, possibly allowing some patients to avoid surgery. The trial will enroll 60 adults aged 18-75 with high-risk features.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER (LARC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China PLAGH
Beijing, China
Conditions
Explore the condition pages connected to this study.